Tilray Brands Reports Record Revenue Amid Diverging Segment Performance

Tilray posts record Q3 revenue of $206.7M, driven by 73% international cannabis growth. Net loss shrinks dramatically to $25.2M, but beverage alcohol revenue falls 24%.

Tilray Brands has delivered a record-breaking revenue performance for its third fiscal quarter of 2026, surpassing market expectations. The company's latest financial results reveal a tale of two distinct trajectories, with international cannabis and pharmaceutical operations surging ahead while the beverage alcohol segment faces significant headwinds.

Financial Performance and Strategic Shifts

The company posted a net revenue increase of eleven percent, reaching $206.7 million. This growth was primarily fueled by exceptional performance in two key areas. Revenue from international cannabis operations saw explosive growth, skyrocketing by 73 percent. Simultaneously, the Tilray Pharma distribution division achieved a record $83 million in sales.

On the profitability front, Tilray made substantial progress. The company dramatically reduced its net loss to $25.2 million, a significant improvement from the prior year's third-quarter net loss of $793.5 million. This financial stabilization is largely attributed to the completion of "Project 420," an efficiency initiative now generating approximately $33 million in annualized cost savings. Adjusted EBITDA climbed 19 percent to $10.7 million.

Management has reaffirmed its full fiscal year 2026 guidance, targeting an adjusted EBITDA range of $62 to $72 million. With a strong liquidity position of $264.8 million, Tilray maintains a solid foundation for future strategic initiatives.

Segment Analysis: Strength and Challenge

A detailed look at the company's business units shows a clear divergence:

• Cannabis Revenue: $64.8 million (19% increase)
• International Cannabis Growth: +73%
• Tilray Pharma Revenue: $83.0 million (35% increase)
• Beverage Alcohol Revenue: $42.6 million (24% decrease)

The beverage alcohol division's performance presented a notable contrast, with revenue declining from $55.9 million in the year-ago period to $42.6 million. This weakness underscores the challenges within this segment despite the company's broader diversification strategy.

Strategic Moves in Beverage and Beyond

Undeterred by recent softness in beverage sales, Tilray continues to aggressively pursue its diversification agenda. Shortly after the quarter's close, the company finalized the acquisition of certain brand rights and assets from the BrewDog brewery for about $44 million. Furthermore, Tilray has entered into a strategic partnership with Carlsberg, set to commence as planned in 2027, which is expected to bolster its global platform.

For the current fiscal year, achieving the stated EBITDA target remains the primary objective. The successful integration of the newly acquired BrewDog assets will be a critical test of Tilray's ability to swiftly address the underperformance in its beverage segment.